EMFO LLC’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$6.63K Hold
644
– – 0.01% 241
2024
Q1
$10.1K Hold
644
– – 0.01% 230
2023
Q4
$10K Hold
644
– – 0.01% 227
2023
Q3
$13K Hold
644
– – 0.01% 225
2023
Q2
$9.25K Hold
644
– – 0.01% 251
2023
Q1
$9.42K Hold
644
– – 0.01% 254
2022
Q4
$7.27K Sell
644
-1,711
-73% -$28.2K 0.01% 249
2022
Q3
$43K Hold
2,355
– – 0.04% 183
2022
Q2
$50K Hold
2,355
– – 0.05% 183
2022
Q1
$73K Hold
2,355
– – 0.07% 171
2021
Q4
$107K Hold
2,355
– – 0.09% 139
2021
Q3
$196K Buy
+2,355
New +$206K 0.17% 105

Other funds holding HELP

EMFO LLC's HELP Position: Q2 2024 in Review

EMFO LLC held its Helus Pharma Inc. Common Stock (HELP) position steady in Q2 2024 at 644 shares worth $6.63K. The position accounts for 0.01% of the portfolio, ranked #241.

EMFO LLC first reported a position in HELP in Q3 2021 and has held it in 12 quarters since. The position peaked at $196K in Q3 2021. 98 funds tracked by Wall St. Rank hold HELP as of Q2 2024.

  • EMFO LLC held 644 shares of Helus Pharma Inc. Common Stock worth $6.63K as of Q2 2024.
  • EMFO LLC left its Helus Pharma Inc. Common Stock share count unchanged in Q2 2024.
  • Helus Pharma Inc. Common Stock made up 0.01% of EMFO LLC's portfolio in Q2 2024, its #241 holding.
  • EMFO LLC first reported a position in Helus Pharma Inc. Common Stock in Q3 2021 and has held it in 12 quarters since.
  • EMFO LLC's Helus Pharma Inc. Common Stock position peaked at $196K in Q3 2021.
  • 98 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2024.

Based on EMFO LLC's 13F filing for Q2 2024, filed 26 Jul 2024.